Scarica l'app Stockscreener
105.54
1.10%
1.15
Dopo l'orario di chiusura:
105.33
-0.21
-0.20%
Precedente Chiudi:
$104.39
Aprire:
$105.01
Volume 24 ore:
117.34K
Relative Volume:
0.69
Capitalizzazione di mercato:
$583.10M
Reddito:
$249.13M
Utile/perdita netta:
$6.71M
Rapporto P/E:
87.40
EPS:
1.2076
Flusso di cassa netto:
$39.58M
1 W Prestazione:
+7.53%
1M Prestazione:
-1.05%
6M Prestazione:
+32.87%
1 anno Prestazione:
+4.88%
Intervallo 1D:
$103.61
$107.67
Intervallo di 1 settimana:
$96.28
$107.67
Portata 52W:
$55.45
$113.99
Mesa Laboratories Inc Stock (MLAB) Company Profile
Nome
Mesa Laboratories Inc
Settore
Industria
Telefono
(303) 987-8000
Indirizzo
12100 W 6TH AVE, LAKEWOOD
Compare MLAB vs COHR, KEYS, GRMN, TDY, MKSI
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MLAB
Mesa Laboratories Inc
|
105.54 | 550.01M | 249.13M | 6.71M | 39.58M | 1.2076 |
COHR
Coherent Corp
|
333.36 | 77.17B | 6.60B | 452.58M | -538.24M | 2.0946 |
KEYS
Keysight Technologies Inc
|
313.86 | 59.83B | 6.09B | 1.07B | 1.36B | 6.0693 |
GRMN
Garmin Ltd
|
240.02 | 45.81B | 7.46B | 1.74B | 1.45B | 8.9685 |
TDY
Teledyne Technologies Inc
|
652.08 | 30.90B | 6.22B | 933.70M | 1.05B | 19.76 |
MKSI
Mks Inc
|
365.56 | 30.04B | 4.07B | 328.00M | 380.00M | 4.7842 |
Mesa Laboratories Inc Stock (MLAB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-07 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Underweight |
| 2024-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-10-02 | Iniziato | JP Morgan | Neutral |
| 2019-12-04 | Iniziato | Jefferies | Buy |
| 2019-08-26 | Iniziato | Evercore ISI | Outperform |
| 2016-06-10 | Downgrade | Sidoti | Buy → Neutral |
Mostra tutto
Mesa Laboratories Inc Borsa (MLAB) Ultime notizie
Mesa Laboratories Inc. (MLAB) Q1 2026 Earnings: Significant EPS Miss Sends Shares LowerDividend Growth Analysis - dars.gov.et
Enterprise value to EBITDA forward of Mesa Laboratories, Inc. – NASDAQ:MLAB - TradingView
Price to book forward of Mesa Laboratories, Inc. – NASDAQ:MLAB - TradingView
Price to sales forward of Mesa Laboratories, Inc. – MUN:MLI - TradingView
Enterprise value to EBIT forward of Mesa Laboratories, Inc. – MUN:MLI - TradingView
Price to earnings forward of Mesa Laboratories, Inc. – NASDAQ:MLAB - TradingView
Price to earnings forward of Mesa Laboratories, Inc. – MUN:MLI - TradingView
Mesa Laboratories, Inc. Actuals & Estimates (NASDAQ:MLAB) - TradingView
MLAB Forecast — Price Target — Prediction for 2027 - TradingView
Mesa Labs CFO John Sakys sells $253k in company stock - Investing.com UK
Mesa Labs SVP Brian Archbold sells $225k in stock after RSU conversion By Investing.com - Investing.com South Africa
Mesa Labs SVP Brian Archbold sells $225k in stock after RSU conversion - Investing.com UK
Mesa Labs CFO John Sakys sells $253k in company stock By Investing.com - Investing.com India
Mesa Labs CAO Crennen sells $39,559 in MLAB shares - Investing.com UK
Mesa Labs CAO Crennen sells $39,559 in MLAB shares By Investing.com - Investing.com South Africa
Mesa Laboratories (MLAB) CAO reports RSU vesting and 442-share tax sale - Stock Titan
Form 4 Mesa Laboratories Inc For: 23 June By Investing.com - Investing.com Canada
Mesa Laboratories (MLAB) SVP exercises RSUs and sells 2,516 shares - Stock Titan
Mesa Laboratories (MLAB) CFO reports grants, RSU conversions and tax-cover share sale - Stock Titan
Form 144 MESA LABORATORIES INC /CO/ For: 22 June By Investing.com - Investing.com Nigeria
MLAB (NASDAQ: MLAB) files Rule 144 for 2,827 vested shares via Fidelity - Stock Titan
MLAB (NASDAQ: MLAB) insider sale notice — 2,516 shares disclosed - Stock Titan
Mesa Laboratories strategy in focus, NASDAQ shares trade in a niche health tech segment - AD HOC NEWS
MLAB SEC FilingsMesa Laboratories 10-K, 10-Q, 8-K Forms - Stock Titan
Mesa Laboratories Inc (MLAB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Mesa Laboratories Inc (MLAB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Mesa Laboratories Inc (MLAB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Mesa Laboratories Inc (MLAB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Mesa Laboratories Inc (MLAB) Institutional Confidence - TradingKey
Mesa Laboratories Inc (MLAB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Mesa Laboratories Inc (MLAB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mesa Laboratories (MLAB) Falls Nearly 5% as Selling Pressure Tests Key SupportLate Stage Breakouts - newsline.com
Insider Sell: Brian Archbold Sells Shares of Mesa Laboratories I - GuruFocus
Mesa Laboratories CAO Lyndsey Crennen sells $11,949 in shares By Investing.com - Investing.com South Africa
Mesa Laboratories Inc (MLAB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mesa Laboratories SVP Brian Archbold sells $116,558 in shares - Investing.com UK
Mesa Laboratories Inc (MLAB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mesa Laboratories SVP Brian Archbold sells $116,558 in shares By Investing.com - Investing.com Nigeria
Mesa Labs CFO John Sakys sells $123,849 of company stock By Investing.com - Investing.com Canada
Mesa Labs CFO John Sakys sells $123,849 of company stock - Investing.com UK
Mesa Laboratories Inc Azioni (MLAB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Mesa Laboratories Inc Azioni (MLAB) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Crennen Lyndsey Elizabeth | CAO |
Jun 22 '26 |
Sale |
89.50 |
442 |
39,560 |
2,020 |
| Archbold Brian David | SVP Operations |
Jun 18 '26 |
Option Exercise |
95.10 |
3,324 |
316,112 |
7,034 |
| Archbold Brian David | SVP Operations |
Jun 22 '26 |
Sale |
89.50 |
2,516 |
225,187 |
6,377 |
| Sakys John | CFO |
Jun 18 '26 |
Option Exercise |
95.10 |
3,792 |
360,619 |
20,330 |
| Sakys John | CFO |
Jun 22 '26 |
Sale |
89.50 |
2,827 |
253,022 |
19,785 |
2.60%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):